Client News

IntelliFlux Controls has launched its brand new web based reporting and decision support toolkit. This toolkit provides plant engineers and operators the ability to access plant performance information from anywhere, anytime. It also makes report generation a matter of “two clicks”.

IntelliFlux remote monitiroing and reporting toolkit is an addition to the core automation platform of Intelliflux. The web component can generate reports in many pre-defined configurations that can be customized to each plant, and every need. The reporting toolkit can also be configured to automatically generate and disseminate reports according to a pre-defined schedule (daily, weekly, monthly). Engineers, managers, and operators can customize the reports from the web-based interface. The flexibility of monitoring and reporting plant performance KPIs from anywhere, and anytime makes IntelliFlux reporting tool an extremely powerful decision support tool.

“At IntelliFlux, our goal is to provide the engineers and operators freedom to monitor the performance of a plant from anywhere, anytime. The reporting tool simplifies one of the tasks of an operator or plant engineer dramatically, the task of collating historical data, and converting them into reports for management, operations, corporate, and even regulatory authorities. IntelliFlux reporting tool is designed to automate this process, so that the operations teams can focus on analyzing the results, instead of devoting time on generating them.”

can you buy Lyrica over the counter – Matt McCallum, Director of Software Engineering

BERKELEY, Calif.–(BUSINESS WIRE)–Lygos, Inc., a vertically integrated provider of safe and sustainable specialty ingredients, today announced a co-development and commercial partnership with High® Beauty, Inc., a leading skincare brand with products powered by Cannabis sativa seed oil formulations. High Beauty will work with Lygos CBx to accelerate the formulation and commercialization of co-branded cosmetic products based upon a wide range of high-quality, pure and naturally derived cannabinoids. The companies plan to begin launching a collection of new skincare products starting in winter 2020. Financial terms of the partnership were not disclosed.

High Beauty has been a pioneer in the formulation of natural, next-generation skincare products. The first High products to launch from this collaboration will be the High & Bye Refining Oil and Clearing Gel, which include Lygos-CBG™ (cannabigerol), a non-psychoactive cannabinoid with antioxidant properties to target blemish-prone skin. High Beauty sells its products through its organic online presence and at many of the leading beauty retailers, including Macy’sKohlsDouglasShoppers Drug MartThe Shopping Choice, and Lookfantastic. Customers can start placing presale online orders and receive limited-time discounts for the High & Bye products.

“High is expertly formulated with Cannabis sativa seed oil in combination with bioflavonoids and terpenes to provide all the nutrients needed for healthy, beautiful skin,” said Melissa Jochim, Founder and Formulator of High Beauty, Inc. “We are now able to enhance our new High & Bye collection with Lygos’ pure Lygos-CBG.”

Using an environmentally safe and highly adaptable methodology, Lygos CBx utilizes its novel production pathway to deliver unique and valuable compounds that are not easily extracted from the plant. The company offers a robust pipeline of multi-functional cannabinoids that feature compelling purity, performance, sustainability, and economic advantages. The cannabinoids are THC-free to ensure a consistent and safe consumer experience.

“Lygos’ proprietary technology platform delivers market-leading quality, purity, and formulation-precision at a significant cost and time-advantage relative to ingredients derived from the Cannabis plant,” said Eric Steen, PhD, CEO of Lygos. “This partnership with the High Beauty team is a huge step forward in the beauty & cosmetic market for the Lygos CBx business. We are now providing kilograms of sustainable products that are naturally inspired and go beyond the plant.”

buy Lyrica mexico About High Beauty

High® Beauty is a revolutionary skincare brand powered by cannabis sativa seed oil that is free of psychoactive substances including THC and CBD. Founded and formulated in Northern California by renowned organic beauty pioneer, Melissa Jochim, High is expertly formulated using Cannabis sativa seed oil in combination with certified organic plant oils, high-potency antioxidants & pure plant essential oils for healthy, beautiful skin. More information can be found at www.highbeauty.com.

Uslar About Lygos CBx

Lygos CBx is a Lygos company focused on low-cost, industrial-scale production of a wide range of high quality, pure and sustainable cannabinoids that are not easily accessible through traditional agricultural means. Lygos CBx is a direct result of the recent NIH-funded Librede acquisition and integration of additional Lygos technology advances. The cannabinoids are designed to enhance numerous consumer products, as well as health & wellness and pharmaceutical applications. For more information, visit cbx.lygos.com.

http://dustinlee.ca/?_escaped_fragment_=/ja-jp/%E6%A4%9C%E7%B4%A2/q=torquel About Lygos

Lygos has created a full-stack biological engineering production platform focused on organic acid specialty chemicals and health & wellness ingredients. Lygos’ sustainable, bio-based chemicals replace expensive, environmentally degrading alternatives from traditional industrial suppliers, enabling customers to create better, safer products with value-added performance. For more information, visit www.lygos.com and follow us @LygosBiotech.

Lygos, Lygos CBx, and the Lygos logo are trademarks of Lygos, Inc. High is a registered trademark of High Beauty, Inc. Any other brands may be trademarks of their respective holders.

Mr. Emrah Ercan joined the Advisory Board of IntelliFlux Controls.   

Mr. Ercan is a senior advisor at Cimbria Capital and the Global Director of Digital Solutions, SUEZ – Water Technologies & Solutions.  Emrah is a member of the SUEZ Innovation and Digital Board of Directors. He joined Suez Water (formerly GE Water) in 2012, bringing more than 15 years of innovation, business development, and commercial leadership experience to the organization. He is responsible for strategic direction, commercialization and development of the company’s digital solutions. 

Previously, Mr. Ercan served as VP of strategic initiatives at GE Oil & Gas and GE Digital. Prior to Suez (GE), Mr. Ercan spent ten years at Ashland, where he worked in commercial operations, business development, and marketing roles. Mr. Ercan holds an MBA from the University of Southern California, an MS in Industrial Engineering from Chalmers University in Sweden, and a BS in Chemical & Process Engineering from Bogazici University in Turkey. In 2013, Mr. Ercan was honored by, then CEO, Jeff Immelt with the GE Corporate Innovation Award.

IntelliFlux Controls, Inc. welcomes Emrah on board as an advisor and looks forward to a great future together. He brings in a unique experience of pioneering digitalization and decision support systems in the water treatment industry. Having the ability to leverage his experience and insights will be pivotal for the company, leading to game changing  advancements in how IntelliFlux Controls offers its technology to achieve transformative results for the water treatment industry.

After rapid integration of NIH-funded Librede technology, company now focused on scaling to commercial quantities and launching new consumer products

BERKELEY, Calif.–(BUSINESS WIRE)–Lygos, Inc., a full-stack provider of sustainable specialty ingredients that deliver high-value performance without environmental toxicity, has announced the successful validation of a novel cannabinoid production pathway using its proprietary fermentation and processing technology. A direct result of the recent Librede acquisition and integration of additional Lygos technology advances, the new fermentation process enables the production of any cannabinoid and cannabinoid-based product of interest in an environmentally safe, sustainable and cost-effective manner at industrial scale (>100 kg) for numerous consumer markets.

Librede, a wholly owned subsidiary of Lygos, had primarily operated on grants from the National Institutes of Health (NIH) prior to the Lygos acquisition. The company’s technology was designed for the low-cost production of a wide range of valuable cannabinoid compounds that are not easily accessible through traditional agricultural means. The platform supports both ultra-rare and common cannabinoids, such as CBD, that feature compelling performance, economic and environmental advantages over traditional plant-based alternatives.

“Librede’s vision was to create a production platform for any cannabinoid at costs to drive widespread consumer access,” said Jason Poulos, PhD, CEO of Librede. “To advance this vision, we needed the ability to access any compound, scale our technology to levels that support consumer product manufacturing, and form key marketing relationships for existing and emerging markets. We have achieved the first of these objectives, have definitive plans for the second, and are working diligently on the third. We are now very close to advancing the platform to provide direct benefit to consumers.”

“We couldn’t be more pleased at the speed with which the Librede and Lygos teams integrated efforts and technologies despite the global pandemic and shutdowns. These rapid advances have accelerated our timetable for forming partnerships and delivering new cannabinoid-enabled products into the market,” said Eric Steen, PhD, CEO of Lygos. “By delivering high quality, pure and sustainable cannabinoids at commercial volumes and competitive prices, we are poised to rapidly enter high-growth consumer market segments with Lygos branded or co-branded products by capitalizing on the expertise and reach of our strategic partners.”

About Lygos

Lygos has created a full-stack biological engineering platform focused on organic acid specialty ingredients, health & wellness ingredients, including cannabinoids and bio-monomers. Lygos’ sustainable, bio-based chemicals replace expensive, environmentally degrading alternatives from traditional industrial suppliers, enabling customers to create better, safer products with value-added performance. For more information, visit www.lygos.com and follow us @LygosBiotech.

About Librede

Librede is a wholly owned subsidiary of Lygos that focuses on the production of high-value natural products. Librede’s proprietary biochemistry platform allows for the production of natural compounds, particularly cannabinoids, in a highly efficient and sustainable manner. More information can be found at www.librede.com.

Lygos, Librede and the Lygos logo are trademarks of Lygos, Inc. Any other brands may be trademarks of their respective holders.

Contacts

Andrew Noble
(415) 722-2129
andrew_noble@noblecomms.com

Joe Zuback

IntelliFlux Controls, Inc. announced that Joseph Zuback, who is a leading global expert in water treatment technologies, has joined the company as a member of its Advisory Board. 

Joe is the president of Global Water Advisors, Inc., and has over forty years of water industry experience as a technology and business developer for municipal, industrial, and commercial water technology markets. Prior to the creation of Global Water Advisors in 2009, he served as the Chief Technology Officer and a member of the Executive Management Council at Siemens Water Technologies (previously USFilter).  He is a board member and vice-chair for the Water Environment Research Foundation and named as inventor or co-inventor for over thirty patents.

“Joe is a personal mentor and a thought leader in the water business. Having him as an advisor for our leadership, management, and technology teams is a rare privilege. I consider this as a spectacular milestone for the company.” said Dr. Richard Woodling, the Chief Commercial Officer at IntelliFlux Controls.

1 2 3